PubMed:24224997 / 204-484 JSONTXT

{"project":"PubMed_Structured_Abstracts","denotations":[{"id":"T1","span":{"begin":0,"end":280},"obj":"BACKGROUND"}],"text":"The TARGIT-A trial compared risk-adapted radiotherapy using single-dose targeted intraoperative radiotherapy (TARGIT) versus fractionated external beam radiotherapy (EBRT) for breast cancer. We report 5-year results for local recurrence and the first analysis of overall survival."}

{"project":"PubmedHPO","denotations":[{"id":"T1","span":{"begin":176,"end":189},"obj":"HP_0003002"},{"id":"T2","span":{"begin":176,"end":189},"obj":"HP_0100013"},{"id":"T3","span":{"begin":183,"end":189},"obj":"HP_0002664"}],"text":"The TARGIT-A trial compared risk-adapted radiotherapy using single-dose targeted intraoperative radiotherapy (TARGIT) versus fractionated external beam radiotherapy (EBRT) for breast cancer. We report 5-year results for local recurrence and the first analysis of overall survival."}

{"project":"Allie","denotations":[{"id":"SS1_24224997_2_0","span":{"begin":72,"end":108},"obj":"expanded"},{"id":"SS2_24224997_2_0","span":{"begin":110,"end":116},"obj":"abbr"},{"id":"SS1_24224997_2_1","span":{"begin":138,"end":164},"obj":"expanded"},{"id":"SS2_24224997_2_1","span":{"begin":166,"end":170},"obj":"abbr"}],"relations":[{"id":"AE1_24224997_2_0","pred":"abbreviatedTo","subj":"SS1_24224997_2_0","obj":"SS2_24224997_2_0"},{"id":"AE1_24224997_2_1","pred":"abbreviatedTo","subj":"SS1_24224997_2_1","obj":"SS2_24224997_2_1"}],"text":"The TARGIT-A trial compared risk-adapted radiotherapy using single-dose targeted intraoperative radiotherapy (TARGIT) versus fractionated external beam radiotherapy (EBRT) for breast cancer. We report 5-year results for local recurrence and the first analysis of overall survival."}